TWB announces the creation of EnobraQ

TWB has announced the creation of EnobraQ, a company that develops yeast capable of using CO2 (atmospheric or of other origins) and transforming it into molecules of interest for the chemical industry. This company, installed at the TWB laboratories, is the product of a TWB research project. Sofinnova Partners, one of Europe’s leaders in venture capital specialized in life sciences and TWB’s partner from the beginning, is the lead investor in EnobraQ.

As a TWB partner, Sofinnova Partners has quickly positioned itself on the Carboyeast project, one of the first research projects selected and self-financed by TWB in 2012 and supported for 3 years by a multidisciplinary team from LISBP (Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés – INSA Toulouse, France), led by Denis Pompon, a CNRS researcher.

Created at the start of November 2015 and presided by Leopold Demiddeleer, EnobraQ seeks to develop a biological process to capture CO2 (atmospheric or from industry) using yeasts for the production of chemical compounds. It is based on a breakthrough innovation which consists in designing a synthetic microorganism (Saccharomyces cerevisiae) which, like plants and microalgae, can use CO2 to produce a wide range of economically interesting chemical molecules.

The creation of a company from TWB self-financed research projects is a result that is highly representative of the movement that TWB seeks to inspire in order to promote research and to speed up the industrialization of processes in biotechnologies.

More information: Press Release


Photo: EnobraQ team, installed at the TWB laboratories